Seven Star Pharmaceutical Co Ltd, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is METHOCARBAMOL, with a corresponding US DMF Number 15596.
Remarkably, this DMF maintains an Active status since its submission on August 27, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 16, 2013, and payment made on April 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II